What should you pay attention to when using daprexostat?

Daprodustat is an oral small molecule drug used to treat anemia, especially anemia caused by chronic kidney disease (CKD). It promotes the production of red blood cells by simulating the action of erythropoietin (EPO). Although it is effective in treating anemia, there are some key things to pay attention to when using it.

Renal function monitoring is essential when using daporostat. Since daprostat is specially designed to treat anemia caused by patients with chronic kidney disease, patients must regularly check renal function indicators, such as serum creatinine, renal tubular filtration rate (eGFR), etc. during medication. In patients who already have severe renal impairment, dose adjustment or consideration of continued use of the drug may be necessary.

Caution must be exercised when using daporostat to treat anemia Assess the severity of anemia and establish reasonable treatment goals. During treatment, hemoglobin (Hb) levels should be monitored regularly and treatment guidelines should be followed to set reasonable hemoglobin target values. Over-treatment may lead to excessively high hemoglobin levels and increase the risk of cardiovascular events or thrombosis, so rushing to reach excessively high hemoglobin values u200bu200bshould be avoided and maintained within an appropriate range.

During the use of daprostat, the patient's cardiovascular health requires special attention. Although this drug is effective in treating anemia, in some people with chronic kidney disease, use of erythropoietin-stimulating (ESA) drugs, including daprostat, may increase the risk of cardiovascular events, such as worsening of heart failure, arrhythmia, or heart attack. Therefore, patients need to regularly evaluate their cardiovascular status during treatment, especially those with a history of heart disease, and should work closely with their doctors to adjust their treatment plan.

Interactions between daprostat and other medications require careful management. Certain drugs, such as potent CYP3A4 inhibitors, may significantly increase the plasma concentration of daprostat, resulting in increased side effects. CYP3A4Inducers may reduce drug effects. Therefore, when using daplostat, patients should report to their doctor any other medications they are taking, including prescription drugs, over-the-counter drugs, and herbal products, to ensure that daplostat can work safely and effectively and to reduce the adverse consequences of drug interactions.